MaxCyte CEO Doug Doerfler retires; Maher Masoud appointed CEO; SPL revenue guidance raised to at least $10M

MAXCYTE, INC.

Doug Doerfler retires as President and CEO effective Dec 31, 2023; remains as advisor.
Maher Masoud, EVP Global Business Development & Chief Counsel, becomes President & CEO on Jan 1, 2024; also joins Board.
Masoud's base salary raised to $590,000 (from $412,500); target bonus 60% of base; receives 400,000 share option grant.
2023 core business revenue guidance reiterated at $28-30M; SPL program revenue now expected at least $10M (above prior guidance).
Doerfler gets 18 months base salary severance, 18 months COBRA, 2023 bonus, and monthly $10K consulting fee for up to 20 hrs.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Doug Doerfler

President, Chief Executive Officer and Director

MXCT · MAXCYTE, INC.

Effective: 2023-12-31
Successor: Maher Masoud
Filed: December 11, 2023, 6:59 PM ET

On December 10, 2023, Doug Doerfler, President and Chief Executive Officer of MaxCyte, Inc. (the “ Company ”), notified the Company’s Board of Directors (the “ Board ”) of his decision to retire from those positions and as a member of the Board, in each case effective as of December 31, 2023 (the “ Retirement Date ”).

Appointed

Maher Masoud

President and Chief Executive Officer

MXCT · MAXCYTE, INC.

Effective: 2024-01-01
Filed: December 11, 2023, 6:59 PM ET

On December 10, 2023, the Board appointed Maher Masoud, currently the Company’s Executive Vice President, General Couns...

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Doug Doerfler retired as President, Chief Executive Officer and Director at MAXCYTE, INC..

Action: retired
Role: President, Chief Executive Officer and Director

Exact text from the filing

On December 10, 2023, Doug Doerfler, President and Chief Executive Officer of MaxCyte, Inc. (the “ Company ”), notified the Company’s Board of Directors (the “ Board ”) of his decision to retire from those positions and as a member of the Board, in each case effective as of December 31, 2023 (the “ Retirement Date ”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Maher Masoud was appointed as President and Chief Executive Officer at MAXCYTE, INC..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

On December 10, 2023, the Board appointed Maher Masoud, currently the Company’s Executive Vice President, General Couns...

View on SEC.gov

MAXCYTE, INC. filing history →

Source: SEC EDGAR

accession 0001558370-23-019718

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.